Related Experiment Video
Updated: Dec 27, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[Risk factors for progression of coronary artery calcification over 5 years in hemodialysis patients]
A Alayoud1, M El Amrani2, M Belarbi3
1Service de néphrologie, dialyse, premier centre médico-chirurgical, Agadir, Maroc; Faculté de médecine et pharmacie Ibn Zohr, Agadir, Maroc.
Insights
Coronary artery calcification progression in dialysis patients is linked to age, diabetes, and inflammation. Early management of chronic kidney disease is key to slowing this cardiovascular risk factor.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Radiology
Background:
- Coronary artery calcification (CAC) is a key cardiovascular morbidity marker.
- Limited research exists on CAC progression in end-stage renal disease (ESRD) patients.
- This study investigates risk factors for CAC changes in dialysis patients.
Purpose of the Study:
- To examine and evaluate risk factors associated with changes in coronary artery calcification (CAC) in patients undergoing hemodialysis.
- To identify predictors of CAC progression in this high-risk population.
Main Methods:
- Coronary artery calcification (CAC) was assessed using 64 multi-slice ultra-fast CT in 28 hemodialysis (HD) patients.
- CAC was measured at baseline and after a five-year follow-up.
- Patients were categorized as progressors or non-progressors based on CAC score changes.
Main Results:
- Slow CAC progression (21.4%) was observed over an average 63-month follow-up.
- Progression was significantly associated with older age, diabetes, male sex, hypercholesterolemia, anemia, inflammation, and hyperphosphatemia.
- Baseline CAC scores strongly predicted 5-year increments, while calcemia, PTH, dialysis duration, tobacco, hypertension, and dialysis dose did not influence progression.
Conclusions:
- CAC progression in dialysis patients is complex and influenced by multiple risk factors, particularly elevated baseline scores.
- Effective management strategies, initiated early in chronic kidney disease, may prevent or slow CAC progression.
- Targeting specific risk factors is crucial for mitigating cardiovascular risk in ESRD patients.
Background:
Although progression of coronary artery calcification (CAC) has been established as an important marker for cardiovascular morbidity, very few studies have studied it in end-stage renal disease patients. Thus we examined and evaluate risk factors of calcification changes in dialysis patients.
Method:
Among 28 hemodialysis (HD) patients, CAC was measured in Agatston units at baseline and after five years using the 64 multi-slice ultra-fast CT. The HD patients were classified as progressors or no progressors according to the change in the CAC score across these 2 measurements.
Results:
Over an average 63 months follow-up, participants without CAC at baseline had no incident CAC. The progression of CAC was slow and was found only in 6 patients (21.4%). It was significantly associated with several cardiovascular risk factors, namely, older age (P=0.03), diabetes (P=0.05), male sex (P=0.02), hypercholesterolemia (P=0.05), anemia (P=0.017), inflammation (P=0.05), and hyperphosphataemia (P=0.012). However, calcemia, parathormone levels, dialysis duration, tobacco, high blood pressure and dialysis dose did not seem to influence the progression of CAC in our series. A strong association was found between basal calcification scores and Delta increment at 5 years.
Conclusions:
Our study suggests that CAC progression in dialysis is a complex phenomenon, associated with several risk factors with special regard to elevated basal scores. This progression can be avoided or slowed with appropriate management, which must begin in the early stages of chronic kidney disease.
Related Concept Videos
Coronary Artery Disease I: Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hemodialysis II: Procedure and Complications
Coronary Artery Disease II: Pathophysiology

